The purpose of this study is to evaluate the amount of active drug in your blood after a dose of the reference product (R).
Healthy post-menopausal females
Body mass index (BMI) between 18.0 kg/m2 to 30.0 kg/m2 inclusive, and weigh at least 50 kg
Have not used tobacco or nicotine products (patches, gums, etc) in the past 1 year
No history of breast cancer or known or suspected carcinoma of the breast
Other inclusion/exclusion criteria will be assessed
This study has been approved by Optimum Clinical Research Ethics Board
Weekdays, Weeknights, Weekends, Overnight
12 days total, 7 sessions
There are two (2) periods in this study, spaced at least 7 days apart. For each study period you will be required to stay at the Cliantha Research facility for approximately 50 hours. You will be required to return to the clinic for 2 visits after each period. A COVID-19 test will be administered prior to each period check-in.
Up to $1970
4520 Dixie Rd Mississauga, Ontario, Canada, L4W 1N2